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ABSTRACT
Aims Despite recognition of the harms related to alcohol misuse and its potential to interfere substantially with
sustained recovery from drug dependency, research evaluating drug treatment outcomes has not addressed the issue
comprehensively. It has been overlooked possibly because treatment research has been framed according to the primary
drug of choice, rather than investigating the interactions between different combinations of drugs and/or alcohol use.
This paper reports on a systematic review investigating whether concurrent alcohol use could impede recovery from
illicit drug use in two potential ways: first, alcohol could become a substitute addiction and/or secondly, alcohol misuse
post-treatmentmay place an individual at risk for relapse to their primary drug problem.Method A systematic search
of four relevant databases was undertaken to identify peer-reviewed, quantitative drug treatment outcome studies that
reported alcohol use pre-, post-treatment and follow-up. Results The search revealed 567 papers, of which 13 were
assessed as fulfilling the key inclusion criteria.The review indicated inconsistent and therefore inconclusive support for
the substitution hypothesis. However, the data revealed consistent support for the hypothesis that alcohol use increases
relapse to drug use. Conclusions (i) The potential negative impact of alcohol misuse on drug treatment outcomes
remains under-researched and overlooked; (ii) alcohol consumption post-drug treatment may increase the likelihood
that an individual will relapse to their primary drug; (ii) existing evidence regarding the substitution hypothesis is
inconclusive, although there was an indication that a subgroup of participants will be vulnerable to alcohol becoming
the primary addiction instead of drugs. We argue that future drug treatment outcome studies need to include detailed
analysis of the influence of alcohol use pre- and post-drug treatment.
Keywords Alcohol misuse, drug dependence, illicit drug use, longitudinal studies, outcomes studies, recovery,
relapse, residential drug treatment, substitution.
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INTRODUCTION
While the social and health-related harms associated
with alcohol misuse are well researched, the lines of
investigation often tend to be conceptualized from a
substance-specific perspective [1]. Research on illicit drug
use is generally framed in relation to the primary drug of
choice, with restricted attention given to other illicit sub-
stances and even less given to the concurrent use of legal
substances, such as alcohol and nicotine [2]. This is likely
to be the natural consequence of the layers of complexity
that multiple variables introduce when investigating
the treatment outcomes of drug dependence. However,
research across a range of western countries has indi-
cated that drug users tend to use or be dependent on
multiple illicit substances and may, contemporaneously,
misuse alcohol [3–8]. We argue in this paper that there is
a need for greater research into homotypic comorbidity
between alcohol and illicit drug use disorders and how
they may interact during treatment for drug depend-
ency [1,9]. For example, in 2003, Gossop and colleagues
reported on alcohol use outcomes among a treatment
sample of drug users and concluded that alcohol use and,
in particular, heavy drinking is an important but under-
estimated problem in the treatment of drug dependency
[10]. However, since then there has been a paucity of
research examining this issue further. Importantly, drug
treatment services (particularly residential services) do
not generally address alcohol misuse specifically [11]. It
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providers operate with a core premise that generic addic-
tion principles are uniformly sufficient for all polydrug
users. These principles, however, fail to take into consid-
eration the position of alcohol in many cultures as a legal
and commonly used substance. This paper proposes that
alcohol misuse may render recovering drug users vulner-
able to relapse and/or ‘substitution’ where they replace
their primary drug with alcohol. To investigate this we
conducted a systematic review of the literature address-
ing the following two questions (taking into account that
they may occur in combination): (i) does alcohol become
a substitute for the primary drug(s) of choice; and (ii)




In order to answer the research questions, the inclusion
criteria for papers in the systematic review were as
follows: (i) quantitative drug treatment outcome studies
that (ii) reported alcohol use pre-, post-treatment and
follow-up; (iii) were limited to peer-reviewed studies
published in English; (iv) and human participants aged
over 18 years. Results were not restricted based on year
of publication. The search (using the terms below) was
conducted in September 2011 across four databases:
Medline, PsychInfo, CINAHL and Academic Search Com-
plete. This search produced 567 papers. Each abstract
was read either by P.S. or B.R. and papers that clearly did
not meet the inclusion criteria were excluded. This left
45 possibly relevant papers which were read in full inde-
pendently by P.S. and B.R. who applied the inclusion cri-
teria to each paper. During this review process papers
were not excluded based on quality of design, but on
whether they provided quantitative treatment outcome
data for drug and alcohol use as per the inclusion crite-
ria (by default excluding qualitative and case studies).
Independent agreement was reached regarding the
exclusion of 35 papers, with a further three being
excluded following further discussion between B.R., P.S.
and C.L.
Search terms
The following search termswere used: drug or ‘substance
*use*’ or ‘substance dependence’ or ‘addict*’ or ‘opiate
*use*’ or ‘heroin *use*’ or ‘amphetamine *use*’ or
‘cocaine *use*’ AND ‘alcohol *use*’ or ‘alcohol problem*’
or alcoholi* or ‘heavy drink*’ or drinking AND ‘treatment
outcome’ or longitudinal or relapse.
The remaining seven were identified as being relevant
to the review. Further searches of reference and citation
lists conducted independently by P.S., B.R. and C.L.
produced another four peer-reviewed papers, one book
chapter and a report that met the inclusion criteria
such that, overall, there were 13 relevant publications, of
which five were relevant to the question of alcohol and
relapse and eight to addressing the substitution hypo-
thesis. These 13 papers were read, summarized and dis-
cussed in detail by P.S., B.R. and C.L. and the ideas and
implications of the papers discussed by all authors.
Does alcohol become a substitute addiction in those
recovering from drug use?
Our review identified eight papers that provided data
addressing the question of whether alcohol becomes a
substitute addiction following recovery from illicit drug
use [10,12–18]. Six of these papers reported on the out-
comes of large-scale longitudinal studies (conducted in
Australia, Ireland, the United States and England) which
reported on the efficacy of various treatments for illicit
drug addiction and documented alcohol consumption
during and after treatment. These longitudinal studies
include the Treatment Outcome Prospective Study
(TOPS; [17]); the Drug Abuse Reporting Program (DARP;
[15,16]); the National Treatment Outcome Study
(NTORS; [10]); the AustralianTreatment Outcome Study
(ATOS; [12]); and the Research Outcome Study (ROSIE;
[13]).
The findings regarding alcohol consumption and its
relationship to drug use pre- and post-treatment were
mixed. The DARP studies [15,16] indicate that overall
alcohol use increased post-treatment at the 1- and 6-year
follow-up time-points while drug use decreased, suggest-
ing indirectly that substitution may be occurring.
Simpson and colleagues [16] found that a small group
of participants reported a direct inverse relationship
between quitting heroin use and increasing alcohol use
post-treatment (13%). Interestingly, alcohol use gradu-
ally declined at the 12-year follow-up mark along with a
concurrent decrease in opioid use, indicating that substi-
tution may occur early post-treatment, but gradually all
drug and alcohol use declined over the 12 years. The
TOPS study findings indicated that alcohol use remained
at problematic levels for recovering drug users despite
an overall decrease in illicit drug use 12 months post-
treatment [17]. The data, however, were analysed in such
a way that it was not possible to examine change at the
level of the individual. Gossop and colleagues [10] specifi-
cally investigated changes in alcohol use among a sub-
sample of NTORS participants, comprised of drug users
in treatment services. Forty-five per cent of individuals
who were abstinent from alcohol at intake were found to
have begun drinking by the 1-year follow-up. However,
when they conducted further analyses to examine if
alcohol use increased in those who had improved drug
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treatment outcomes (i.e. substitution hypothesis) they
did not find any significant effects. Gossop and colleagues
concluded that heavy drinking post-drug treatment
should be viewed more as a function of general polydrug
use rather than substitution, although caution needs to
be taken when interpreting these findings, as the sample
size (n = 62) for those with improved drug treatment out-
comes was low [10].
Findings from the ROSIE data [13] indicated that 15%
of users who reported no alcohol at baseline consumed
alcohol 1 year later; however, whether they were also
abstinent (i.e. suggesting substitution) from illicit drugs
was not reported. Darke et al. [12] found no inverse rela-
tionship between reduced heroin use and alcohol con-
sumption at follow-up. However, similar to the TOPS
study, their analyses did not investigate change in alcohol
and heroin use at the individual level, only on average
within the sample. Furthermore, this study did not report
the specific level of alcohol consumption, making it
difficult to ascertain whether drinking was a problem at
either baseline or follow-up. These measurement issues
make it difficult to investigate the substitution hypothesis
appropriately, a conclusion also offered in 1979 by
Belenko [19] in a narrative review on the use of alcohol
among illicit drug users.
Almog and colleagues [14] reported on the use of
alcohol in 375 males who were in drug-free or metha-
done treatment programmes. They found an inverse
relationship between heroin and alcohol use in the pre-
treatment, treatment and discharge phases (except for
Anglo participants in the methadone programme who,
it could be argued, are already substituting). Finally,
DeLeon [18] conducted a 2-year follow-up of individuals
treated within a Therapeutic Community. Alcohol use
among illicit drug-dependent individuals was low post-
treatment, although there was a subgroup who reported
high alcohol use pre- and post-treatment for drug use.
These findings did not provide support for alcohol sub-
stitution, although the author notes that clients may
be reluctant to report alcohol use following treat-
ment, given the abstinence model of the Therapeutic
Community.
In summary, evidence for the substitution hypothesis
is mixed (one supporting, another supporting in a sub-
group, three unclear and three finding no evidence), and
therefore inconclusive. It is possible that more in-depth
qualitative studies will also shed light on this inter-
relationship; however, it is likely that there are consider-
able individual differences at play, suggesting that
subgroups of recovering users might be especially at risk
(e.g. [16]). For example, Lehman & Simpson [20] argued
that substitution with alcohol might be higher in
individuals with a history of alcohol abuse and familial
alcoholism.
Does alcohol use post-treatment lead to relapse to illicit
drug use?
Five studies were identified as addressing the question of
whether alcohol consumption may be related to relapse
to illicit drug use following drug treatment [10,11,21–
23]. In one study by Mengis and colleagues [22], alcohol
use at 4 weeks (but not at baseline) predicted relapse
to cocaine use for clients being treated using cognitive–
behavioural therapy (CBT) or a 12-Step programme
(n = 128). In particular, alcohol use at 4 weeks was asso-
ciated positively with relapse to cocaine use at 8 and 12
weeks and alcohol use atweek 8 predicted cocaine relapse
at week 12. Stenbacka and colleagues [11] examined
alcohol use in a group attending methadone mainte-
nance treatment (n = 204), and found that those who
relapsed to illicit drug use were more likely to test positive
for alcohol use than participants who did not relapse
[11]. Furthermore, the authors found that more fre-
quent users of alcohol, as evidenced by four or more posi-
tive screens for alcohol use, experienced more relapse
episodes.
McKay and colleagues [21] found that 98 cocaine-
dependent participants who were able to abstain from
alcohol consumption had better drug use outcomes
following treatment. Furthermore, drinking following
treatment was found consistently to be associated with
worse cocaine use outcomes 6months later. Themajority
of participants (61.9%) reported drinking on the day of
their relapse at the 6-month follow-up, although the
authors note that the analyses did not allow interpreta-
tion of whether or not the alcohol triggered a relapse to
cocaine use. Finally, alcohol use post-treatment had a
stronger relationship to subsequent cocaine relapse than
a diagnosis of alcohol dependency at intake to treatment
[21]. Gossop and colleagues [10] found that participants
(n = 418) who engaged in ongoing heavy drinking from
intake onwards, or those who increased alcohol use fol-
lowing treatment, were more likely to be using illicit sub-
stances 6 months later. Finally, a small study (n = 20) by
Frawley & Smith [23] looked at the relationship between
alcohol use during chemical aversion treatment and
relapse to cocaine use. They found that alcohol use at
6 months was associated significantly with relapse at 18
months for individuals treated for alcohol and cocaine
use (n = 11), but not for individuals treated for cocaine
use only (n = 9). The small sample size limits the conclu-
sions that can be drawn.
In summary, all five studies provide some support for
the proposition that the use of alcohol may contribute to
relapse to drug use. Three of the studies showed an asso-
ciation between alcohol use and relapse within a single
time-point [11,21,23]. The other two studies found that
alcohol use at an earlier time-point predicted relapse at a
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later time-point [10,22]. While there is some evidence
that alcohol use may contribute to relapse for some indi-
viduals, the studies cited do not provide an understand-
ing of the nature of this relationship nor the possible
mechanisms involved. We suggest that further empirical
and qualitative studies are necessary in order to under-
stand the possible mechanisms involved if alcohol use
does indeed trigger relapse to drug use, especially if
this relationship is only substantial for a subgroup of
individuals.
DISCUSSION
Currently there is limited research that examines speci-
fically the trajectory of alcohol use in recovering
drug-dependent clients. By reviewing 13 studies which
included data on the alcohol use of clients recovering
from drug dependence, we have identified sufficient evi-
dence to warrant further investigation of the effects of
alcohol misuse on drug treatment outcomes. These find-
ings need to be interpreted in light of the exclusion of
non-English papers and participants aged under 18
years. Also, it is likely that the influence of alcohol will
differ based on cultural and legal variation between
countries, and this review is possibly more relevant in
countries where alcohol is legally available. Keeping
these limitations in mind, there is consistent (albeit
a small number of studies) evidence to indicate that
alcohol consumption post-drug treatment increases the
likelihood that an individual will relapse to their primary
drug. The data were mixed and generally lacking in
sufficient detail to draw any conclusions regarding the
substitution hypothesis, although there was an indica-
tion that a subgroup of participants will be vulnerable
to alcohol becoming the primary addiction instead of
drugs.
Thirty years ago a number of researchers identified
the lack of studies investigating the issue of alcohol use
among drug users and the potential negative impact it
plays in recovery (see [19]). Since then we have pro-
gressed little in our understanding of this issue, due pri-
marily to the lack of studies reporting detailed alcohol
consumption data pre- and post-drug treatment. This
review found only 13 studies which provided these data.
These 13 studies generally examined overall increases
or decreases in alcohol and drug use, which limits our
ability to understand the individual interactions between
drug use recovery and the use of alcohol. We argue that
there is a need for studies to examine explicitly the sub-
stitution hypothesis and the role of alcohol in relapse to
illicit drug use (e.g. using cross-lagged models or latent
growth modelling and mixture modelling) to identify
subgroups especially at risk.
Given the findings, it is important to consider the
potential underlying mechanisms at play in the two sce-
narios examined in this review. In the context of relapse
prevention, possible hypotheses regarding underlying
mechanisms include alcohol use as a compensatory drug
to manage cravings, a consequence of addictive behav-
iour in clients with histories of polysubstance use [24]
and, secondly, the possible detrimental effect that alcohol
has on impulse control and decision-making on clients
recovering from drug dependency. These findings
highlight the ongoing need for relapse prevention pro-
grammes to identify and address possible triggers for
relapse in the recovering drug user (i.e. [25]), of which
alcohol is possibly a prime candidate of risk. Finally,
recent animal studies into the reward pathways of the
brain suggest that drug addictionmay alter the dopamine
pathways in the brain, and hence it is possible that the
recovering drug user may be more vulnerable to depend-
ency (and therefore substitution) to other drugs via cross-
tolerance and cross-sensitization [26,27]. This line of
research implies that individuals recovering from drug
use may need to abstain from all drugs of addiction,
including alcohol. It is, of course, equally possible that
alcohol and illicit drug use simply co-occur, rather than
alcohol leading to relapse to drug use. It is also likely
that multiple reasons explain simultaneously the appar-
ent relationship between alcohol use during and post-
treatment and relapse.
Finally, it is important to consider the treatment impli-
cations of this review. Residential drug treatment has
documented success in impacting on chronic illicit drug
use (e.g. [28]); however , these programmes may some-
times overlook the harm of alcohol use [18]. The cultural
ubiquity and legality of alcohol use in western countries,
in particular, may have allowed its potential as a signifi-
cant threat to sustained recovery from drug misuse
to be underestimated in drug treatment programmes.
Treatment programmes tend to include content which
is relevant to the use of all psychoactive substances,
but alcohol may occupy a substantially different niche in
many societies compared with other drugs of addiction.
We argue that if alcohol use is not addressed specifically
in drug treatment programmes, then recovering drug
users may be at risk of poor outcomes and health-related
harm. This situation may also apply to other harmful
legal drugs such as nicotine. For example, Gudyish and
colleagues have raised the issue of nicotine addiction not
being addressed in drug treatment, despite the inarguable
harms related to smoking and the high prevalence of use
in this population [29,30]. In a review of staff surveys,
the lack of interventions for smoking in drug treatment
programmes was attributed most frequently to limita-
tions in staff knowledge of how to assess and treat
smoking [29]. It may also be related to the idea that
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depriving clients of all substances of addiction is too
severe, and will interfere with their ability to stay in treat-
ment and remain abstinent from their primary addiction.
However, the counter-argument for this is the possibility
that addiction fundamentally changes the reward path-
ways in the brain [26,27], making substance users more
vulnerable to any drugs of addiction and suggesting that
dependent users need to abstain from all psychoactive
drugs post-treatment. These issues all warrant further
investigation and discussion if we are to increase drug
treatment efficacy.
In conclusion, we argue that the role of alcohol use in
relation to recovery from drug dependency has been
underestimated and overlooked. Very few studies have
directly investigated this issue. This is particularly the
case with regard to the potential risks of vulnerability to
relapse triggered by alcohol misuse and/or substitution
of alcohol for the drug of choice. This review raises a
number of areas for further research in addition to rec-
ommending that drug treatment programmes consider
including a specific intervention concentrated on alcohol
skills-based training focused on relapse prevention and
the harms related to alcohol misuse. This would be a nec-
essary step in protecting clients from inadvertently com-
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